NEW YORK, NY / ACCESSWIRE / January 12, 2018 / Pomerantz LLP is investigating claims on behalf of investors of INC Research Holdings, Inc. ("INCR" or the "Company") (NASDAQ: INCR). Such investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 9980.
The investigation concerns whether INCR and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here to join a class action]
On August 1, 2017, INCR announced that it had completed a merger with inVentiv Health, Inc. ("inVentiv"). The Company represented to investors that the inVentiv merger raised its expectations for revenue growth and profitability. On November 9, 2017, INCR announced its financial and operating results for the first quarter since the inVentiv merger, reporting a net loss of $88.9 million, as well as impairment charges to the Company's intangible assets.
On this news, INCR's share price fell $16.35, or 28.43%, to close at $41.15 on November 9, 2017.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
SOURCE: Pomerantz LLP